| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.935 | 6.614 | 7.575 | 9.970 | 11.492 | 8.782 | 10.133 | 4.206 | 0 | 0 |
| Total Income - EUR | 6.013 | 6.614 | 7.575 | 9.970 | 11.492 | 9.356 | 10.133 | 4.206 | 0 | 0 |
| Total Expenses - EUR | 5.537 | 6.301 | 6.751 | 7.203 | 7.744 | 6.780 | 8.562 | 4.980 | 158 | 15 |
| Gross Profit/Loss - EUR | 476 | 313 | 825 | 2.768 | 3.748 | 2.576 | 1.571 | -774 | -158 | -15 |
| Net Profit/Loss - EUR | 296 | 180 | 749 | 2.668 | 3.633 | 2.516 | 1.571 | -774 | -158 | -15 |
| Employees | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Melacrino S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2 | 0 | 22 | 2.745 | 4.229 | 4.211 | 3.216 | 340 | 181 | 165 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 226 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 2 | 0 | 22 | 2.519 | 4.229 | 4.211 | 3.216 | 340 | 181 | 165 |
| Shareholders Funds | -1.418 | -1.223 | -453 | 2.223 | 3.692 | 3.657 | 2.681 | 340 | 181 | 165 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.419 | 1.223 | 475 | 522 | 537 | 554 | 535 | 0 | 0 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9602 - 9602" | |||||||||
| CAEN Financial Year |
9602
|
|||||||||
Comments - Melacrino S.r.l.